Firefly Neuroscience, Inc.
AIFF
$2.24
$0.2613.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.48% | 38.47% | -45.02% | -1,052.41% | -251.44% |
| Total Depreciation and Amortization | 700.00% | 900.00% | -100.00% | -- | -- |
| Total Amortization of Deferred Charges | -63.64% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.15% | -67.21% | 539.66% | 18,866.10% | 1,592.65% |
| Change in Net Operating Assets | -76.86% | 134.91% | -1,042.72% | -208.59% | 171.94% |
| Cash from Operations | -48.19% | 40.93% | -117.47% | -90.37% | -138.82% |
| Capital Expenditure | 71.25% | -2,050.00% | 81.25% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 101.04% |
| Cash from Investing | 69.74% | 3.37% | -1,210.50% | 94.66% | 80.31% |
| Total Debt Issued | 29.46% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2,716.05% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 50.79% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -86.66% | -100.55% | -- | 984.97% | -12.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -372.07% | -282.68% | -183.36% | 1,631.68% | -53.60% |